💬 Today’s #MicrobiomeFact : Did you know? Recent studies were conducted to determine the interplay of gut microbiota and conditioning in the development of aGVHD.
👉 swll.to/oUCfg

🔔The #microbiome session of the 2022 edition of HTID is available on replay👉youtube.com/watch?v=SBcZ8E…
Industry leaders including our CEO Hervé Affagard & world-renowned specialists discussed how the gut microbiota is becoming a cornerstone in treating serious diseases & cancer.

We are also thrilled to announce that Herve Affagard in his capacity as President of Alliance Promotion Microbiote is an invited speaker and will present during the IHMC2022Kobe Congress.

👉More details to follow – meet the speakers: ihmc2022.jp/speakers.html

📅 [EVENT]- Herve Affagard, CEO and cofounder of MaaT Pharma and Aurore DUQUENOY, R&D specialist, will attend the IHMC2022Kobe Congress in Kobe, Japan from November 8th to 10th in 2022.

👉 ihmc2022.jp/index.html

The monthly meeting ! MaaT Pharma

MaaT Pharma has been shortlisted as a finalist for the European Lifestars Awards in the category IPO of the Year. Congratulations to all finalists and thanks for this nomination!

👉 lnkd.in/g-k5fms

Results will be announced on November 14 in London, see you then!

👏Lancé il y a un mois, Le French Gut, qui souhaite faire avancer la #science du #microbiote en France, rencontre du succès !🦠Bravo pour cette initiative qui permettra en partie de cartographier et comprendre les microbiotes intestinaux des Français.
👉lnkd.in/emsR6RQ8

📢 [EVENT] – Join Isabelle Adeline, our Chief of Staff, Director PMO, Regulatory Affairs, QA and IP, at the inaugural Operationalise Early Access Programmes Summit Europe Hanson Wade.
👉 lnkd.in/eiSWjqFV

💬 Today’s #MicrobiomeFact : Did you know? Several studies have reported a pattern of co-occurrence of dementia with certain gastrointestinal tract (GIT) disorders with links with microbiota dysbiosis.

👉 lnkd.in/gyHwe54W

#microbiome #science

Last round table of the 1st day dedicated to Translational microbiome medicine to treat serious oncology and infectious diseases with experts: Isabelle de Cremoux Herve Affagard Carl Bilbo Mohamad Mohty Tim Sharpington and Hassane M. Zarour - Watch live: lnkd.in/eiXtkBnW

“The era of Microbiome therapy is here and now” Carl Bilbo Ferring Pharmaceuticals HealthTech Innovation Days #HTID4

“We are building a new class of medecine to improve patients’ outcomes in cancer”Herve Affagard HealthTech Innovation Days #HTID4
“Phase 3 in just 7 years” Isabelle de Cremoux

“Microbiome intervention may improve clinical outcome of ICIs and may decrease occurrence of serious adverse events upon ICIs” Hassane Zarour HealthTech Innovation Days

“Modulation of microbiota is the next frontier in cancer care” Mohamad Mohty HealthTech Innovation Days #HTID4